KR20240096883A - 나이브 보바인 배아 줄기 세포의 유도 - Google Patents

나이브 보바인 배아 줄기 세포의 유도 Download PDF

Info

Publication number
KR20240096883A
KR20240096883A KR1020247019582A KR20247019582A KR20240096883A KR 20240096883 A KR20240096883 A KR 20240096883A KR 1020247019582 A KR1020247019582 A KR 1020247019582A KR 20247019582 A KR20247019582 A KR 20247019582A KR 20240096883 A KR20240096883 A KR 20240096883A
Authority
KR
South Korea
Prior art keywords
embryo
medium
embryos
ecm
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247019582A
Other languages
English (en)
Korean (ko)
Inventor
레미 라브렉
시-중 장
Original Assignee
더 세메스 얼라이언스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 세메스 얼라이언스 filed Critical 더 세메스 얼라이언스
Publication of KR20240096883A publication Critical patent/KR20240096883A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020247019582A 2021-11-12 2022-11-11 나이브 보바인 배아 줄기 세포의 유도 Pending KR20240096883A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163278751P 2021-11-12 2021-11-12
US63/278,751 2021-11-12
PCT/CA2022/051664 WO2023082007A1 (en) 2021-11-12 2022-11-11 Derivation of naïve bovine embryonic stem cells

Publications (1)

Publication Number Publication Date
KR20240096883A true KR20240096883A (ko) 2024-06-26

Family

ID=86334866

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247019582A Pending KR20240096883A (ko) 2021-11-12 2022-11-11 나이브 보바인 배아 줄기 세포의 유도

Country Status (10)

Country Link
US (1) US20250002843A1 (https=)
EP (1) EP4430161A4 (https=)
JP (1) JP2024544563A (https=)
KR (1) KR20240096883A (https=)
CN (1) CN118843687A (https=)
AR (1) AR131803A1 (https=)
AU (1) AU2022387152A1 (https=)
CA (1) CA3237860A1 (https=)
MX (1) MX2024005704A (https=)
WO (1) WO2023082007A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025052161A1 (en) * 2023-09-06 2025-03-13 Iamfluidics Holding B.V. Substrate and method
WO2025123144A1 (en) * 2023-12-14 2025-06-19 The Semex Alliance Derivation of bovine naïve stem cells using feeder cells
CN120966740B (zh) * 2025-10-14 2026-04-10 西北农林科技大学 无饲养层、无血清的牛胚胎干细胞培养基、培养体系及培养方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150037883A1 (en) * 2013-03-03 2015-02-05 Royan Institute Method for derivation and long-term establishment of ground state pluripotent embryonic stem cells
CN105531365A (zh) * 2013-04-23 2016-04-27 耶达研究及发展有限公司 分离的幼稚多能干细胞和产生所述细胞的方法
CN108064274A (zh) * 2014-07-30 2018-05-22 耶达研究及发展有限公司 用于培养多能干细胞的培养基
CN118652837A (zh) * 2018-01-12 2024-09-17 加利福利亚大学董事会 稳定的多能牛胚胎干细胞的高效衍生

Non-Patent Citations (26)

* Cited by examiner, † Cited by third party
Title
Anderson KGV, Hamilton WB, Roske F V., Azad A, Knudsen TE, Canham MA, Forrester LM and Brickman JM (2017) Insulin fine-tunes self-renewal pathways governing naive pluripotency and extra-embryonic endoderm. Nature Cell Biology 19 1164-1177.
Bishop TF and Van Eenennam AL. (2020) Genome editing approaches to augment livestock breeding programs. J Exp Biol. 223 (Suppl_1): jeb207159.. doi: 10.1242/jeb.207159.
Bogliotti YS, Wu J, Vilarino M, Okamura D, Soto DA, Zhong C, Sakurai M, Sampaio RV, Suzuki K, Izpisua Belmonte JC et al. (2018) Efficient derivation of stable primed pluripotent embryonic stem cells from bovine blastocysts. Proceedings of the National Academy of Sciences of the United States of America 115 2090-2095.
Bredenkamp N, Stirparo GG, Nichols J, Smith A and Guo G (2019) The Cell-Surface Marker Sushi Containing Domain 2 Facilitates Establishment of Human Naive Pluripotent Stem Cells. Stem Cell Reports 12.
Cosin-Roger J, Ortiz-Masia MD and Barrachina MD (2019) Macrophages as an emerging source of wnt ligands: Relevance in mucosal integrity. Frontiers in Immunology 10 2297.
De Los Angeles A (2019) Frontiers of Pluripotency. Methods in Molecular Biology 2005 3-27.
Gafni O, Weinberger L, Mansour AA, Manor YS, Chomsky E, Ben-Yosef D, Kalma Y, Viukov S, Maza I, Zviran A et al. (2013) Derivation of novel human ground state naive pluripotent stem cells. Nature 504.
Guo G, Von Meyenn F, Santos F, Chen Y, Reik W, Bertone P, Smith A and Nichols J (2016) Naive Pluripotent Stem Cells Derived Directly from Isolated Cells of the Human Inner Cell Mass. Stem Cell Reports 6.
Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, Soldner F, Cassady JP, Muffat J, Carey BW and Jaenisch R (2010) Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proceedings of the National Academy of Sciences of the United States of America 107 9222-9227.
Hou Z, An L, Han J, Yuan Y, Chen D and Tian J (2018) Revolutionize livestock breeding in the future: an animal embryo-stem cell breeding system in a dish. Journal of Animal Science and Biotechnology 2018 9:1 9 1-11.
Kawaguchi T, Tsukiyama T, Kimura K, Matsuyama S, Minami N, Yamada M and Imai H (2015) Generation of Naive Bovine Induced Pluripotent Stem Cells Using PiggyBac Transposition of Doxycycline-Inducible Transcription Factors. PLOS ONE 10 e0135403.
Khan SA, Park K mi, Fischer LA, Dong C, Lungjangwa T, Jimenez M, Casalena D, Chew B, Dietmann S, Auld DS et al. (2021) Probing the signaling requirements for naive human pluripotency by high-throughput chemical screening. Cell Reports 35.
Kim H, Wu J, Ye S, Tai CI, Zhou X, Yan H, Li P, Pera M and Ying QL (2013) Modulation of β-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nature Communications 4.
Lerman MJ, Lembong J, Muramoto S, Gillen G and Fisher JP (2018) The Evolution of Polystyrene as a Cell Culture Material. Tissue Engineering - Part B: Reviews 24.
Li R, Zhong C, Yu Y, Liu H, Sakurai M, Yu L, Min Z, Shi L, Wei Y, Takahashi Y et al. (2019) Generation of Blastocyst-like Structures from Mouse Embryonic and Adult Cell Cultures. Cell 179 687-702.e18.
Liu X, Tan JP, Schroder J, Aberkane A, Ouyang JF, Mohenska M, Lim SM, Sun YBY, Chen J, Sun G et al. (2021) Modelling human blastocysts by reprogramming fibroblasts into iBlastoids. Nature 591 627-632.
Park F. (2007) Lentiviral vectors: are they the future of animal transgenesis? Physiol Genomics. 31: 159-173.
Smith, LC, Labrecque, R, Paredes LMA, Therrien J, and Vigneault, C. 2020. Use of haploid embryonic cells to generate offspring with predetermined genomes. WO 2020/168422.
Solter D and Knowles BB (1975) Immunosurgery of mouse blastocyst. Proc Natl Acad Sci USA 72(12):099-102
Soto DA, Navarro M, Zheng C, Halstead MM, Zhou C, Guiltinan C, Wu J and Ross PJ (2021). Simplification of culture conditions and feeder-free expansion of bovine embryonic stem cells. Scientific Reports 2021 11:1 11 1-15.
Talbot NC, Sparks WO, Powell AM, Kahl S and Caperna TJ (2012) Quantitative and semiquantitative immunoassay of growth factors and cytokines in the conditioned medium of STO and CF-1 mouse feeder cells. In Vitro Cellular & Developmental Biology. Animal 48 1-11.
Theunissen TW, Powell BE, Wang H, Mitalipova M, Faddah DA, Reddy J, Fan ZP, Maetzel D, Ganz K, Shi L et al. (2014) Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell 15.
Wang S, Qu Z, Huang Q, Zhang J, Lin S, Yang Y, Meng F, Li J, and Zhang K. (2022) Application of Gene Editing Technology in Resistance Breeding of Livestock. Life (Basel). 12:1070. doi: 10.3390/life12071070.
Yanagida A, Spindlow D, Nichols J, Dattani A, Smith A and Guo G (2021) Naive stem cell blastocyst model captures human embryo lineage segregation. Cell Stem Cell 28.
Yu L, Wei Y, Duan J, Schmitz DA, Sakurai M, Wang L, Wang K, Zhao S, Hon GC and Wu J (2021) Blastocyst-like structures generated from human pluripotent stem cells. Nature 591 620-626.
Zhao L, Gao X, Zheng Y, Wang Z, Zhao G, Ren J, Zhang J, Wu J, Wu B, Chen Y et al. (2021) Establishment of bovine expanded potential stem cells. Proceedings of the National Academy of Sciences of the United States of America 118.

Also Published As

Publication number Publication date
AU2022387152A1 (en) 2024-06-20
US20250002843A1 (en) 2025-01-02
MX2024005704A (es) 2024-06-26
WO2023082007A1 (en) 2023-05-19
CA3237860A1 (en) 2023-05-19
EP4430161A1 (en) 2024-09-18
CN118843687A (zh) 2024-10-25
AR131803A1 (es) 2025-05-07
JP2024544563A (ja) 2024-12-03
EP4430161A4 (en) 2026-01-14

Similar Documents

Publication Publication Date Title
KR20240096883A (ko) 나이브 보바인 배아 줄기 세포의 유도
JP2023002805A (ja) 多能性細胞のデノボ生成
US6436701B1 (en) Derivation of pluripotential embryonic cell lines from ungulate species
Brevini et al. Parthenotes as a source of embryonic stem cells
Madeja et al. Beyond the mouse: Non-rodent animal models for study of early mammalian development and biomedical research
CN118652837A (zh) 稳定的多能牛胚胎干细胞的高效衍生
US20130302887A1 (en) Compositions and methods for growing human embryonic cells
JP2023011931A (ja) 多能性細胞に関連する方法
Liu et al. Developments in cell culture systems for human pluripotent stem cells
Zhi et al. Elucidation of the pluripotent potential of bovine embryonic lineages facilitates the establishment of formative stem cell lines
Mohapatra et al. Establishment of trophectoderm cell lines from buffalo (Bubalus bubalis) embryos of different sources and examination of in vitro developmental competence, quality, epigenetic status and gene expression in cloned embryos derived from them
Ren et al. The building blocks of embryo models: embryonic and extraembryonic stem cells
Wang et al. A universal 6iL/E4 culture system for deriving and maintaining embryonic stem cells across mammalian species
CN115927166A (zh) 一种大鼠原始内胚层干细胞分离建系的方法
Halstead et al. Maternal Med12 safeguards trophoblast pluripotency and placental development
KR20250166285A (ko) 소 배아 복제의 비클로닝 방법
Lee et al. In vitro culture of chicken embryonic stem cell-like cells
WO2025123144A1 (en) Derivation of bovine naïve stem cells using feeder cells
Mitrisin Effects of Activin A and Fibroblast Growth Factor 2 on Bovine Embryonic Stem Cell Differentiation
Pock The effect of growth factor supplemented ART culture media on whole mouse embryo development
CN102586174A (zh) 源于白内障疾病模型小鼠的多潜能细胞、其制备方法及其用途
Gurer et al. Therapeutic use of cloning: Osmangazi turk identical embryonic stem cells and embryonic stem cell transfer to diabetic mice
Ying Using Mouse Embryonic Fibroblast (MEF) as Feeder Cells for Production of Embryonic Stem Cell (ESC) Line in the Murine and Caprine

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240612

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application